Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Cleanability and Re-Usability of Cadence™ Inline Diafiltration Modules
Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release
By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer
Beyond Quality: PAT as a Catalyst for Carbon Reduction in Pharma
Productivity and Economic Advantages of Coupling Single-Pass Tangential Flow Filtration to Multi-Column Chromatography for Continuous Processing
Mark Schofield, Ph.D., Karl Rogler, Xhorxhi Gjoka, Engin Ayturk, Ph.D., and René Gantier, Ph.D.
View All Featured ArticlesHeadline News
Tezspire improves symptoms and histologic remission in Phase III eosinophilic esophagitis trial
RYBREVANT FASPRO combination shows 77% response rate in first-line advanced head and neck cancer
Sone-Ve cuts risk of death by 42% in Phase III advanced gastric cancer trial
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Antisense Oligonucleotide Purification Process: Successes and Challenges During Scale-up
Presented by Robert Gronke, Ph.D., Senior Principal Scientist, Technical Development, Biogen and Thomas Müller-Späth, Ph.D, CTO at YMC ChromaCon
10th March 2020
Harnessing the Power of Data Analytics to Derive Process Intelligence for Pharma Manufacturing
Presented by Santosh Whatkar, Senior Manager, Automation and Digital Technology at Pfizer
05th March 2020
Transformational Science: Moving from Challenges of High Concentration Protein Formulations Development to Meet the Needs of High Potent Bispecifics
Presented by Sachin Dubey, Ph.D., Head of Formulation and Analytical Development at Glenmark Pharmaceuticals SA
19th March 2019
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Strategy Emerging Markets for Risk Mitigation
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Lifetime study for JSR Amsphere A3 – protein A resin
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products















